KT
ARIA

Kanaly Trust’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Kanaly Trust’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-500
Closed -$3K – 746
2014
Q4 		$3K Hold
500
– – ﹤0.01% 599
2014
Q3 		$3K Hold
500
– – ﹤0.01% 667
2014
Q2 		$3K Hold
500
– – ﹤0.01% 621
2014
Q1 		$4K Hold
500
– – ﹤0.01% 599
2013
Q4 		$3K Buy
+500
New +$2.7K ﹤0.01% 524

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kanaly Trust's ARIA Position: Q1 2015 in Review

Kanaly Trust sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2015, closing a stake of 500 shares — an estimated $3K sold.

Kanaly Trust first reported a position in ARIA in Q4 2013 and held it in 5 quarters. The position peaked at $4K in Q1 2014. 193 funds tracked by Wall St. Rank hold ARIA as of Q1 2015.

  • Kanaly Trust reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Kanaly Trust sold 500 Ariad Pharmaceuticals Inc shares in Q1 2015, an estimated $3K.
  • Kanaly Trust first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 5 quarters.
  • Kanaly Trust's Ariad Pharmaceuticals Inc position peaked at $4K in Q1 2014.
  • 193 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2015.

Based on Kanaly Trust's 13F filing for Q1 2015, filed 28 Apr 2015.